Exploring the fate of liposomes in the intestine by dynamic in vitro lipolysis

International Journal of Pharmaceutics

Volumn 437, Issue 1-2, 2012, Pages 253-263

  Parmentier, Johannes ^a   Thomas, Nicky ^b   Müllertz, Anette ^c   Fricker, Gert ^a   Rades, Thomas ^b,c  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF OTAGO   (New Zealand)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Bile salts; Danazol; Dynamic light scattering; In vitro lipolysis; Liposome stability; Scanning ion occlusion sensing

Indexed keywords

DANAZOL; LIPOSOME; PANCREAS ENZYME; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID;

ARTICLE; CONCENTRATION (PARAMETERS); DISTRIBUTION VOLUME; DRUG DELIVERY SYSTEM; DRUG FORMULATION; FEASIBILITY STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; INTESTINE; LIGHT SCATTERING; LIPID COMPOSITION; LIPID DEGRADATION; LIPID HYDROLYSIS; LIPOLYSIS; MOLECULAR SIZE; MOLECULAR STABILITY; PRECIPITATION; PRIORITY JOURNAL; TITRIMETRY;

DANAZOL; INTESTINES; LIPOLYSIS; LIPOSOMES; PARTICLE SIZE; PHOSPHATIDYLCHOLINES;

EID: 84866733513     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.08.018     Document Type: Article

References (63)

1. E. Afergan, M. Ben David, H. Epstein, N. Koroukhov, D. Gilhar, K. Rohekar, H.D. Danenberg, and G. Golomb Liposomal simvastatin attenuates neointimal hyperplasia in rats AAPS J. 12 2010 181 187
2. M. Anderson, and A. Omri The effect of different lipid components on the in vitro stability and release kinetics of liposome formulations Drug Deliv. 11 2004 33 39
3. Y. Aramaki, H. Tomizawa, T. Hara, K. Yachi, H. Kikuchi, and S. Tsuchiya Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration Pharm. Res. 10 1993 1228 1231
4. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
5. M. Bayomi, A. Al-Angary, M. Al-Meshal, and M. Al-Dardiri In vivo evaluation of arteether liposomes Int. J. Pharm. 175 1998 1 7
6. S. Chakraborty, D. Shukla, B. Mishra, and S. Singh Lipid - an emerging platform for oral delivery of drugs with poor bioavailability Eur. J. Pharm. Biopharm. 73 2009 1 15
7. C. Chiang, and N. Weiner Gastrointestinal uptake of liposomes. I: in vitro and in situ studies Int. J. Pharm. 37 1987 75 85
8. C. Chiang, and N. Weiner Gastrointestinal uptake of liposomes. II: in vivo studies Int. J. Pharm. 40 1987 143 150
9. 2 (Naja naja naja) J. Biol. Chem. 258 1983 6327 6334
10. E.A. Dennis Phospholipases - Phospholipid Enzymology. The Enzymes vol. 3 1983 Academic Press New York pp. 307-353
11. D.G. Fatouros, and A. Mullertz In vitro lipid digestion models in design of drug delivery systems for enhancing oral bioavailability Expert Opin. Drug Metab. 4 2008 65 76
12. C. Figarella, F. Clemente, and O. Guy A zymogen of phospholipase A in human pancreatic juice Biochim. Biophys. Acta 227 1971 213 217
13. J. Filipović-Grcić, N. Skalko-Basnet, and I. Jalsenjak Mucoadhesive chitosan-coated liposomes: characteristics and stability J. Microencapsul. 18 2001 3 12
14. G. Fricker, and J. Drewe Current concepts in intestinal peptide absorption J. Pept. Sci. 2 1996 195 211
15. G. Fricker, T. Kromp, A. Wendel, A. Blume, J. Zirkel, H. Rebmann, C. Setzer, R.-O. Quinkert, F. Martin, and C. Müller-Goymann Phospholipids and lipid-based formulations in oral drug delivery Pharm. Res. 27 2010 1469 1486
16. F. Gabor, C. Fillafer, L. Neutsch, G. Ratzinger, and M. Wirth Improving oral delivery M. Schäfer-Korting, Drug Delivery, Handbook of Experimental Pharmacology vol. 197 2009 Springer Berlin/Heidelberg, Germany 345 398
17. P. Garidel, A. Hildebrand, K. Knauf, and A. Blume Membranolytic activity of bile salts: influence of biological membrane properties and composition Molecules 12 2007 2292 2326
18. E. Garza-Licudine, D. Deo, S. Yu, A. Uz-Zaman, and W.B. Dunbar Portable Nan particle unitization using a resizable nanopore instrument - the IZON qNano™ Conf Proc IEEE Eng Med Boil Soc 2010 2010 5736 5739
19. M. Gaumet, A. Vargas, R. Gurny, and F. Delie Nan particles for drug delivery: the need for precision in reporting particle size parameters Eur. J. Pharm. Biopharm. 69 2008 1 9
20. E. Gjone, E. Ofstad, P. Marton, and E. Amundsen Phospholipase activity in pancreatic exudates in experimental acute pancreatitis Scand. J. Gastroenterol. 2 1967 181 185
21. G. Gregoriadis The carrier potential of liposomes in biology and medicine (second of two parts) N. Engl. J. Med. 295 1976 765 770
22. M. Grove, G.P. Pedersen, J.L. Nielsen, and A. Mullertz Bioavailability of seocalcitol (III): administration of lipid-based formulations to minipigs in the fasted and fed state Eur. J. Pharm. Sci. 31 2007 8 15
23. A. Hildebrand, K. Beyer, R. Neubert, P. Garidel, and A. Blume Solubilization of negatively charged DPPC/DPPG liposomes by bile salts J. Colloid Interface Sci. 279 2004 559 571
24. A. Hildebrand, R. Neubert, P. Garidel, and A. Blume Bile salt induced solubilization of synthetic phosphatidylcholine vesicles studied by isothermal titration calorimetry Langmuir 18 2002 2836 2847
25. K.Y. Hostetler, and L.B. Hall Phospholipase C activity of rat tissues Biochem. Biophys. Res. Commun. 96 1980 388 393
26. I. Ihse, B. Arnesjö, C. Kugelberg, and P. Lilja Intestinal activities of trypsin, lipase, and phospholipase after a test meal. An evaluation of 474 examinations Scand. J. Gastroenterol. 12 1977 663 668
27. A. Jesorka, and O. Orwar Liposomes: technologies and analytical applications Annu. Rev. Anal. Chem. 1 2008 801 832
28. T.T. Kararli Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals Biopharm. Drug Dispos. 16 1995 351 380
29. K. Kleberg, F. Jacobsen, D.G. Fatouros, and A. Mullertz Biorelevant media simulating fed state intestinal fluids: colloid phase characterization and impact on solubilization capacity J. Pharm. Sci. 99 2010 3522 3532
30. M. Kokkona, P. Kallinteri, D. Fatouros, and S.G. Antimisiaris Stability of SUV liposomes in the presence of cholate salts and pancreatic lipases: effect of lipid composition Eur. J. Pharm. Sci. 9 2000 245 252
31. V.V. Kumar, B. Malewicz, and W.J. Baumann Lysophosphatidylcholine stabilizes small unilamellar phosphatidylcholine vesicles. Phosphorus-31 NMR evidence for the wedge effect Biophys. J. 55 1989 789 792
32. J. Laine, S. Bourgoin, J. Bourassa, and J. Morisset Subcellular distribution and characterization of rat pancreatic phospholipase D isoforms Pancreas 20 2000 323 336
33. A. Larsen, R. Holm, M.L. Pedersen, and A. Muellertz Lipid-based Formulations for danazol containing a digestible surfactant, Labrafil M2125CS: in vivo bioavailability and dynamic in vitro lipolysis Pharm. Res. 25 2008 2769 2777
34. A.T. Larsen, P. Sassene, and A. Müllertz In vitro lipolysis models as a tool for the characterization of oral lipid and surfactant based drug delivery systems Int. J. Pharm. 417 2011 245 255
35. C. Lipinski, F. Lombardo, B. Dominy, and P. Feeney Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3 25
36. V.J. Mohanraj, T.J. Barnes, and C.A. Prestidge Silica Nan particle coated liposomes: a new type of hybrid nanocapsule for proteins Int. J. Pharm. 392 2010 285 293
37. K. Muramatsu, Y. Maitani, and T. Nagai Dipalmitoylphosphatidylcholine liposomes with soybean-derived sterols and cholesterol as a carrier for the oral administration of insulin in rats Biol. Pharm. Bull. 19 1996 1055 1058
38. F. Nacka, M. Cansell, and B. Entressangles In vitro behavior of marine lipid-based liposomes. Influence of pH, temperature, bile salts, and phospholipase A2 Lipids 36 2001 35 42
39. J.A. Op den Kamp, J. de Gier, and L.L. van Deenen Hydrolysis of phosphatidylcholine liposomes by pancreatic phospholipase A2 at the transition temperature Biochim. Biophys. Acta 345 1974 253 256
40. J. Parmentier, M.M. Becker, U. Heintz, and G. Fricker Stability of liposomes containing bio-enhancers and tetraether lipids in simulated gastro-intestinal fluids Int. J. Pharm. 405 2011 210 217
41. G.B. Patel, B.J. Agnew, L. Deschatelets, L.P. Fleming, and G.D. Sprott In vitro assessment of archaeosome stability for developing oral delivery systems Int. J. Pharm. 194 2000 39 49
42. H. Patel, and B.E. Ryman Oral administration of insulin by encapsulation within liposomes FEBS Lett. 62 1976 60 63
43. H.M. Patel, R.W. Stevenson, J.A. Parsons, and B.E. Ryman Use of liposomes to aid intestinal absorption of entrapped insulin in normal and diabetic dogs Biochim. Biophys. Acta 716 1982 188 193
44. A.I. Polozova, G.E. Dubachev, T.N. Simonova, and L.I. Barsukov Temperature-induced micellar-lamellar transformation in binary mixtures of saturated phosphatidylcholines with sodium cholate FEBS Lett. 358 1995 17 22
45. P. Potluri, and G. Betageri Mixed-micellar proliposomal systems for enhanced oral delivery of progesterone Drug Deliv. 13 2006 227 232
46. E. Ralston, R. Blumenthal, J.N. Weinstein, S.O. Sharrow, and P. Henkart Lysophosphatidylcholine in liposomal membranes: enhanced permeability but little effect on transfer of a water-soluble fluorescent marker into human lymphocytes Biochim. Biophys. Acta 597 1980 543 551
47. R.N. Rowland, and J.F. Woodley The stability of liposomes in vitro to pH, bile salts and pancreatic lipase Biochim. Biophys. Acta 620 1980 400 409
48. R.N. Rowland, and J.F. Woodley Uptake of free and liposome-entrapped insulin by rat intestinal sacs in vitro Biosci. Rep. 1 1981 345 352
49. R. Schubert, K. Beyer, H. Wolburg, and K.H. Schmidt Structural changes in membranes of large unilamellar vesicles after binding of sodium cholate Biochemistry 25 1986 5263 5269
50. R. Schubert, and K.H. Schmidt Structural changes in vesicle membranes and mixed micelles of various lipid compositions after binding of different bile salts Biochemistry 27 1988 8787 8794
51. R. Singh, S. Singh, and J.W. Lillard Past, present, and future technologies for oral delivery of therapeutic proteins J. Pharm. Sci. 97 2008 2497 2523
52. Y. Snitko, S. Han, B. Lee, and W. Cho Differential interfacial and substrate binding modes of mammalian pancreatic phospholipases A(2): a comparison among human, bovine, and porcine enzymes Biochemistry-Us 38 1999 7803 7810
53. H. Sonoda, J. Aoki, T. Hiramatsu, M. Ishida, K. Bandoh, Y. Nagai, R. Taguchi, K. Inoue, and H. Arai A novel phosphatidic acid-selective phospholipase A1 that produces lysophosphatidic acid J. Biol. Chem. 277 2002 34254 34263
54. F. Szoka, and D. Papahadjopoulos Comparative properties and methods of preparation of lipid vesicles (liposomes) Annu. Rev. Biophys. Bioeng. 9 1980 467 508
55. M. Taira, N. Chiaramoni, K. Pecuch, and S. Alonso-Romanowski Stability of liposomal formulations in physiological conditions for oral drug delivery Drug Deliv. 11 2004 123 128
56. M. Takahashi, S. Uechi, K. Takara, Y. Asikin, and K. Wada Evaluation of an oral carrier system in rats: bioavailability and antioxidant properties of liposome-encapsulated curcumin J. Agric. Food Chem. 57 2009 9141 9146
57. H. Takeuchi, H. Yamamoto, T. Niwa, T. Hino, and Y. Kawashima Mucoadhesion of polymer-coated liposomes to rat intestine in vitro Chem. Pharm. Bull. 42 1994 1954 1956
58. H. Tanaka, I. Mierau, and F. Ito Purification and characterization of bovine pancreatic bile salt activated lipase J. Biochem. - Tokyo 125 1999 883 890
59. N. Thomas, R. Holm, T. Rades, and A. Müllertz In vitro lipolysis and its implication on the development of lipid-based drug delivery systems AAPS J. 2012 10.1208/s12248-012-9398-6
60. M. Werle, and H. Takeuchi Chitosan-aprotinin coated liposomes for oral peptide delivery: development, characterisation and in vivo evaluation Int. J. Pharm. 370 2009 26 32
61. G. Willmott, and L. Bauerfeind Detection of polystyrene sphere translocations using resizable elastomeric nanopores 2010 arXiv:1002.0611
62. N. Zangenberg, A. Mullertz, H. Kristensen, and L. Hovgaard A dynamic in vitro lipolysis model I. Controlling the rate of lipolysis by continuous addition of calcium Eur. J. Pharm. Sci. 14 2001 115 122
63. N. Zangenberg, A. Mullertz, H. Kristensen, and L. Hovgaard A dynamic in vitro lipolysis model II: evaluation of the model Eur. J. Pharm. Sci. 14 2001 237 244